Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04200157 · ClinicalTrials.gov registry record
Testing the Decoy Effect to Increase Tobacco Treatment Uptake
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 600
- Enrollment target
NCT04200157: Completed study, sponsored by NYU Langone Health.
NCT04200157 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 600 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04200157 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
Study Summary
Prior research has shown that the context in which program options are presented to consumer impacts consumer choice (known as the 'decoy effect'). The aims of this study are to: (1) test whether the decoy effect can impact smokers' selection of hypothetical tobacco treatment options; (2) examine sociodemographic moderators of the decoy effect; and and (3) examine whether presenting the time and clinical effectiveness of of the different treatment options modifies the decoy effect.
Interventions
- OTHER Online survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2018-09-10 |
| Est. Completion | 2019-07-22 |
What the finished NCT04200157 record still lists
NCT04200157 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Online survey is the first listed.
NCT04200157 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04200157 about?
NCT04200157 is a clinical study titled "Testing the Decoy Effect to Increase Tobacco Treatment Uptake". Prior research has shown that the context in which program options are presented to consumer impacts consumer choice (known as the 'decoy effect'). The aims of this study are to: (1) test whether the decoy effect can impact smokers' selection of hypothetical tobacco treatment options; (2) examine so...
What is the current status of trial NCT04200157?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2018-09-10. Estimated completion is 2019-07-22.
What interventions are being tested in trial NCT04200157?
The interventions under investigation include: Online survey (OTHER).
Who is sponsoring clinical trial NCT04200157?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI